Serum-fragmented CK18 (fCK18) levels, which reflect overall liver function, the degree of liver fibrosis, and the progression of HCC, could be used as a potential predictor of survival in HCC patients. This evidence concerns the gene KRT18 and hepatocellular carcinoma.